Head and Neck Cancer Stage III: Clinical Trials

2 completed, 1 recruiting. 2 Phase 2, 1 Not applicable.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 2
Not applicable	1	Recruiting 1

Follow Head and Neck Cancer Stage III: new trials by email Literature Review of Head and Neck Cancer Stage III trials Research Report on Head and Neck Cancer Stage III

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Virtual Rehabilitation for Cancer Survivors CaRE@Home intervention - Breast Cancer, Stage 0, Colorectal Cancer Stage I	Not applicable	Recruiting	University Health Network, Toronto	388	2023-07-07	2026-09-24
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer Pembrolizumab, Tadalafil - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma	Phase 2	Completed	University of California, San Diego	7	2020-04-07	2026-02-12
IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma IPI-549 - Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer	Phase 2	Completed	Assuntina G. Sacco, MD	16	2020-03-06	2025-07-25

Narrower conditions

Head and Neck Neoplasms (3)  ·  Carcinoma (2)  ·  Neoplasms (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Breast Carcinoma In Situ (1)  ·  Breast Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Lymphoma (1)  ·  Lymphoproliferative Disorders (1)  ·  Mouth Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Parkinson Disease 4, Autosomal Dominant Lewy Body (1)  ·  Pyridoxine-dependent epilepsy (1)

Broader conditions

Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Carcinoma, Squamous Cell (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Carcinoma in Situ (1)  ·  Colonic Diseases (1)  ·  Esophageal Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)

Interventions

IPI-549 (1)  ·  Tadalafil (1)  ·  pembrolizumab (1)

Sponsors

Assuntina G. Sacco, MD (1)  ·  University Health Network, Toronto (1)  ·  University of California, San Diego (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Ezra Cohen, MD (1)  ·  Jennifer Jones, PhD (1)  ·  Joseph Califano (1)